RSC-1255
Based on 1 Customer Validation
RSC-1255 is a potent and selective Vacuolar H⁺-ATPase (V-ATPase) inhibitor that directly binds the mammalian V-ATPase complex with a Kd = 23 nM. RSC-1255 exhibits preferential cytotoxicity toward KRAS-mutant cancer cells, especially KRASG13D and KRASG12V cells. RSC-1255 induces apoptosis and blocks lysosomal acidification, autophagy, and macropinocytosis in cancer cells. RSC-1255 can be used for the study of KRAS-driven lung and colon cancers.
For research use only. We do not sell to patients.
- Purity : 99.91%
- CAS No.: 2171015-78-2
- Formula: C27H25ClF4N4O3
- Molecular Weight:564.96
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
IC50 & Target
[1]|
KRAS G13D |
KRas G12V |
In Vitro
RSC-1255 (249C) (1 μM; 1 h) inhibits V-ATPase–mediated proton pumping and lysosomal acidification in HEK293T cells[1].
RSC-1255 (1 μM; 1 h) disrupts V-ATPase assembly by increasing membrane-associated V1 subunits in HEK293T cells[1].
RSC-1255 exhibits potent growth-inhibitory activity in human cancer cell lines, with IC50 values of 0.073 μM in A549 (KRAS-mutant), 0.06 μM in LOX IMVI (BRAFV600E), and 0.022μM in MelJuso (HRASG13D/NRASQ61L) cells[1].
RSC-1255 (0-10 μM; 72 h) selectively reduces cell viability in KRAS-mutant mouse embryonic fibroblasts (MEFs) with the highest sensitivity in KRASG13D and KRASG12V cells[1].
RSC-1255 (1 μM; 2-24 h) blocks autophagic flux, increasing SQSTM1/p62 and LC3-II accumulation in A549 cells[1].
RSC-1255 (1 μM; 1 h) increases lysosomal pH in KRASG13D MEFs, reversing their highly acidic basal lysosomal state[1].
RSC-1255 (1 μM; 1 h) inhibits V-ATPase–dependent proton transport in FITC-loaded lysosomes, showing the strongest inhibition in KRASG13D MEFs[1].
RSC-1255 (1 μM; 24 h) enlarges autophagic vesicles and blocks lysosome-autophagosome fusion in KRASG13D, KRASG12V and BRAFV600E MEFs[1].
RSC-1255 (1 μM; 2 h) markedly reduces macropinocytosis levels in MEFs, with KRASG13D cells showing the strongest suppression[1].
RSC-1255 ((1 μM; 24 h) induces apoptosis in KRAS-mutant MEFs, with KRASG13D, KRASG12V and BRAFV600E cells showing the highest Annexin V⁺/PI⁺levels[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HEK293T cells
-
Concentration:1 μM
-
Incubation Time:1h
-
Result:Increased membrane-associated V1 subunit B2 was observed, indicating altered V-ATPase assembly after treatment.
-
Cell Line:A549 cells
-
Concentration:1 μM
-
Incubation Time:2 , 4 , 8 , 20 , 24 h
-
Result:Time-dependent accumulation of SQSTM1/p62 and LC3-II, indicating autophagic flux inhibition.
-
Cell Line:MEF KRAS mutants (KRASG13D, KRASG12V, KRASG12D, KRASG12S, KRASG12C, KRASQ61L, KRASQ61R, WT)
-
Concentration:0-10 μM
-
Incubation Time:72 h
-
Result:Highest sensitivity in KRASG13D and KRASG12V MEFs with the lowest IC50 values; minimal sensitivity in WT MEFs.
-
Cell Line:MEFs expressing KRASG13D, KRASG12V, BRAFV600E and other KRAS mutants
-
Concentration:1 μM
-
Incubation Time:24h
-
Result:Increased of Annexin V+/PI+ apoptotic cells, with KRASG13D,KRASG12V and BRAFV600E MEFs showing the strongest apoptotic responses.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:A549 (KRASG12S) lung cancer xenografts were established in five-week-old athymic mice.
-
Dosage:10 mg/kg
-
Administration:Intraperitoneal injection (i.p.); twice daily
-
Result:Significantly reduced tumor volumes in A549 xenograft-bearing mice during the treatment period.
Increased LC3-I/II levels in tumor tissues, indicating autophagy inhibition in vivo.
No significant systemic toxicity, with normal body weight, organ weights and hematological parameters.
-
Animal Model:SW48 xenograft models bearing parental or KRAS-mutant SW48 cells (KRASG12D/+, KRASG12V/+, KRASG13D/+) were established in five-six-week-old athymic mice].
-
Dosage:10 mg/kg
-
Administration:Intraperitoneal injection (i.p.); 2 weeks.
-
Result:Significant tumor growth inhibition in KRAS-mutant SW48 xenografts, with the strongest effects in KRASG13D/+ and KRASG12V+ tumors.
Minimal response in parental SW48 tumors, consistent with lower in vitro sensitivity.
No significant changes in body weight or systemic toxicity during treatment.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 2171015-78-2
-
Appearance Solid
-
Molecular Weight 564.96
-
Formula C27H25ClF4N4O3
-
Color Off-white to light yellow
-
SMILES
O=C(C1(C)N(C2=CC=C(C=C2F)F)N=C(C1C3=CC=C(Cl)O3)C4=C(F)C=C(F)C=C4)NCC5OCCN(C5)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (282 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)